Literature DB >> 21249234

Dual-use research and technological diffusion: reconsidering the bioterrorism threat spectrum.

Jonathan E Suk1, Anna Zmorzynska, Iris Hunger, Walter Biederbick, Julia Sasse, Heinrich Maidhof, Jan C Semenza.   

Abstract

Entities:  

Mesh:

Year:  2011        PMID: 21249234      PMCID: PMC3020926          DOI: 10.1371/journal.ppat.1001253

Source DB:  PubMed          Journal:  PLoS Pathog        ISSN: 1553-7366            Impact factor:   6.823


× No keyword cloud information.
The global security community continues to view a potential bioterrorist event with concern. Kofi Annan, former Secretary General of the United Nations, stated “the most important under-addressed threat relating to terrorism…is that of terrorists using a biological weapon” [1]. The European Commission believes that biological weapons “may have particular attractions for terrorists” [2]. The United States Commission on the Prevention of Weapons of Mass Destruction Proliferation and Terrorism believes it is very likely that a weapon of mass destruction will be used in a terrorist attack by the end of 2013, and that an attack with a biological weapon is more likely than one with a nuclear weapon [3]. There is good reason for concern. Infectious diseases elicit instinctive fears that some terrorist organizations appear to have the intent to exploit [4]. The 2001 anthrax attacks in the United States, believed to have been caused by a single actor [5], were a keen reminder of the ability of bioterrorism to cause death and societal disruption. Such concerns have been linked to the rapid progress in life science research. The most advanced techniques 20 years ago are today routine (and some, like DNA synthesis, are also much cheaper [6]), while new fields, notably synthetic biology [7], [8], have opened frontiers previously inconceivable. Furthermore, expertise in life science research is globally dispersed, and methodologies for synthesizing and/or altering the virulence of pathogens in the laboratory have already been published in high-profile scientific journals. Activities that have garnered substantial attention include chemically synthesizing the poliovirus [9] and the ΦX174 bacteriophage [10], demonstrating the importance of a variola virus gene for its virulence [11], and reconstituting the 1918 influenza virus [12]. Each has been classified as dual use research of concern (DURC), which is defined by the US National Science Advisory Board for Biosecurity (NSABB) as “research that, based on current understanding, can be reasonably anticipated to provide knowledge, products, or technologies that could be directly misapplied by others” [13]. DURC creates a tension between freedom of research and national security [14]–[17]. As security communities have pushed for tighter oversight of research, scientific communities have been quick to grasp that certain biosecurity regulations, such as export controls [18] or visa controls for foreign scientists [19], run the risk of being inadvertently disruptive [20]–[24]. Members of the US NSABB have even argued that the inhibition of life science research could be considered a threat to national security and public health in and of itself [25]. Yet as concerns the rationale for biosecurity controls, the scientific community has been generally muted. Although this may be related to the secrecy surrounding intelligence about terrorist organizations, classified snippets of information should not have priority over expert technical input. Ceding the debate to the security community could lead to inaccurate threat assessments and the adoption of inappropriate biosecurity control measures. The European Centre for Disease Prevention and Control (ECDC) was established in 2005 with the mandate to strengthen Europe's defenses against infectious diseases through developing European Union–wide surveillance networks and early warning systems, coordinating scientific studies, and identifying emerging health threats [26]. As a part of ECDC efforts to evaluate potential bioterrorism threats, we reviewed 27 assessments (published between 1997 and 2008) that address the links between life science research and bioterrorism with the objective of identifying DURC relevant for public health (Text S1). The focus of the review was limited to the application of DURC by terrorist organizations and it did not consider state-sponsored biological weapons programs. The 27 assessments were selected based upon a literature review and interviews with a panel of international experts. Collectively, the 27 assessments explicitly cite a wide range of DURC activities. Based upon these, we conducted a threat assessment during an expert workshop. The purpose of this threat assessment was to identify those DURC activities that would be the most easily deployed by bioterrorists. The key parameters for this assessment were the level of expertise required for conducting any given DURC activity and the level of equipment required to conduct the work. In the threat assessment, an estimated threat level was calculated for each DURC activity by giving a score ranging from 1 (high threshold) to 3 (low threshold) for both parameters, and then multiplying these scores to yield the final threat, which could be 1, 2, 3, 4, 6, or 9. Higher scores indicate a higher likelihood of success if they were to be undertaken by bioterrorists (Text S1). The overall ranking provides an indication of the threat spectrum related to the ability of bioterrorists to exploit life science research (Table 1), and it suggests that “low tech” activities may be especially attractive to bioterrorists. This opposes the tendency of biosecurity discussions to be rather more focused on “high tech” research: typically, the potential negative consequences of research falling into the wrong hands are accentuated while the likelihood of this occurring is inadequately considered. Is the availability of material, methodologies, and high-level expertise, none of which should be taken for granted, even adequate for the development of a sophisticated bioweapon? Technology is much more than the sum of its material and informational aspects. Social contingencies and tacit knowledge, serendipity and unpredictability, institutional memory, and many other factors are essential to the successful design and deployment of any given technology, including (if not especially) biological weapons [27], [28]. Interviews with the Wimmer group about the poliovirus synthesis [9], for example, highlight that replicating the experiment is a very challenging and time-consuming procedure even for virologists familiar with the experimental system [29]. It is not obvious that extrapolating the methods from this work for other purposes—or to another laboratory—would have been successful. The challenge is surely even greater when resource, time, or other constraints (such as the need to be clandestine) are involved.
Table 1

Threat assessment for research areas of concern.

Expertise ThresholdLow – (3)Medium – (2)High – (1)Equipment ThresholdLow – (3)Medium – (2)High – (1)Threat Level
Enhance the dissemination of a biological agent by contamination of food or water supplies late in a distribution chain339
Increase the environmental stability of a biological agent by mechanical means, e.g., microencapsulation224
Confer resistance to therapeutically useful antibiotics or antiviral agents224
Facilitate the production of biological agents224
Enhance the dissemination of a biological agent by contamination of food or water supplies early in a distribution chain313
Enhance the dissemination of a biological agent as powder or aerosol122
Synthetic creation of viruses212
Render a vaccine ineffective111
Enhance the virulence of a biological agent111
Increase the transmissibility of a biological agent111
Enhance the infectivity of a biological agent111
Alter the host range of a biological agent111
Render a non-pathogenic biological agent virulent111
Insertion of virulence factors111
Enhance the resistance of a biological agent to host immunological defence111
Insertion of host genes into a biological agent to alter the immune or neural response111
Generate a novel pathogen111
Increase the environmental stability of a biological agent by genetic modification111
Enable the evasion of diagnostic or detection modalities111
Targeting materials to specific locations in the body111

Calculated according to the formula total threat  =  (expertise threshold) × (equipment threshold), this table presents individual DURC activities according to the ease with which a terrorist organization could be expected to replicate the work, based on expertise and equipment thresholds. The highest threat level comes from DURC activities that were deemed to require overcoming only low expertise and low equipment thresholds (such as contaminating a food or water source with an unaltered pathogen). Conversely, the lowest threat comes from highly sophisticated DURC activities that would need to overcome high equipment and expertise thresholds, such as those that would be required to substantially alter the genetic nature of a pathogen.

Calculated according to the formula total threat  =  (expertise threshold) × (equipment threshold), this table presents individual DURC activities according to the ease with which a terrorist organization could be expected to replicate the work, based on expertise and equipment thresholds. The highest threat level comes from DURC activities that were deemed to require overcoming only low expertise and low equipment thresholds (such as contaminating a food or water source with an unaltered pathogen). Conversely, the lowest threat comes from highly sophisticated DURC activities that would need to overcome high equipment and expertise thresholds, such as those that would be required to substantially alter the genetic nature of a pathogen. The recent history of bioterrorism also suggests that more attention should be allotted to low tech threats [30]. An extensive review of biocrimes in the 20th century argued that although bioterrorists might acquire some capabilities, there is “reason to doubt the ease with which such groups could cause mass casualties” [31]. Aum Shinrikyo, for example, was not successful in procuring, producing, or dispersing anthrax and botulinum toxin in the 1990s, while Al Qaeda is believed to have failed to obtain and work with pathogens by the early 2000s [32], and this likely remains the case. In comparison, the contamination of food and water, and direct injection/application of a pathogen, all have much lower technical hurdles and might be expected to be rather more successfully deployed [31]. The best-known example is the contamination of salad bars with Salmonella by the Rajneeshee cult in 1984, which led to roughly 751 illnesses and 45 hospitalizations [33]. It remains the only known incident in which a terrorist organization, rather than an individual, deployed a biological agent in the US [31]. We do not suggest that high tech bioterrorism threats do not exist—rather, that their likelihoods should be re-evaluated. Biosecurity policy discussions could gain more nuance and credibility by adopting more sophisticated notions about the challenges inherent in conducting and replicating advanced research. The life sciences community has an obvious self-interest in this, and might best achieve it by emphasizing the oft-unacknowledged factors inherent to successful high tech research, including those related to social contingencies and tacit knowledge. Thus far, when life scientists have entered the fray, they have tended to reinforce the “high-tech” perspective, even if their objectives have been to argue against strict biosecurity controls and/or to encourage the life sciences to engage in debates about the risks and benefits of its research [34]–[36]. Many agree about the importance of threat mitigation measures that prepare for the eventuality of a bioterrorism attack, irrespective of its source [37], [38]. Examples include encouraging the development of diagnostics, vaccines, and therapeutics, as well as empowering public health agencies to strengthen defenses against communicable diseases. Such approaches have the additional advantage that they take the broadest possible view of the threat spectrum by also preparing for attacks by the most successful “bioterrorists” of all, nature and globalization, which have led to the emergence of numerous new communicable diseases in recent years [39]–[41]. A focus on strengthening global health security has been put forward by the Obama administration [42] and the European Commission [38], and has also gained prominence in fora such as the Biological and Toxin Weapons Convention [43]. Public health, too, is dual use: it can be leveraged to counter natural and intentional disease outbreaks. Dual-use assessments reviewed in this study (in reverse chronological order). (0.05 MB PDF) Click here for additional data file.
  22 in total

1.  Effects of the USA PATRIOT Act and the 2002 Bioterrorism Preparedness Act on select agent research in the United States.

Authors:  M Beatrice Dias; Leonardo Reyes-Gonzalez; Francisco M Veloso; Elizabeth A Casman
Journal:  Proc Natl Acad Sci U S A       Date:  2010-05-10       Impact factor: 11.205

2.  Chemical synthesis of poliovirus cDNA: generation of infectious virus in the absence of natural template.

Authors:  Jeronimo Cello; Aniko V Paul; Eckard Wimmer
Journal:  Science       Date:  2002-07-11       Impact factor: 47.728

3.  Public health. National security and the biological research community.

Authors:  Ronald M Atlas
Journal:  Science       Date:  2002-10-25       Impact factor: 47.728

4.  Science and government. Biosecurity and research: minimizing adverse impacts.

Authors:  Jennifer Gaudioso; Reynolds M Salerno
Journal:  Science       Date:  2004-04-30       Impact factor: 47.728

5.  The pace and proliferation of biological technologies.

Authors:  Robert Carlson
Journal:  Biosecur Bioterror       Date:  2003

6.  The "nuclearization" of biology is a threat to health and security.

Authors:  David R Franz; Susan A Ehrlich; Arturo Casadevall; Michael J Imperiale; Paul S Keim
Journal:  Biosecur Bioterror       Date:  2009-09

7.  Creation of a bacterial cell controlled by a chemically synthesized genome.

Authors:  Daniel G Gibson; John I Glass; Carole Lartigue; Vladimir N Noskov; Ray-Yuan Chuang; Mikkel A Algire; Gwynedd A Benders; Michael G Montague; Li Ma; Monzia M Moodie; Chuck Merryman; Sanjay Vashee; Radha Krishnakumar; Nacyra Assad-Garcia; Cynthia Andrews-Pfannkoch; Evgeniya A Denisova; Lei Young; Zhi-Qing Qi; Thomas H Segall-Shapiro; Christopher H Calvey; Prashanth P Parmar; Clyde A Hutchison; Hamilton O Smith; J Craig Venter
Journal:  Science       Date:  2010-05-20       Impact factor: 47.728

8.  Variola virus immune evasion design: expression of a highly efficient inhibitor of human complement.

Authors:  Ariella M Rosengard; Yu Liu; Zhiping Nie; Robert Jimenez
Journal:  Proc Natl Acad Sci U S A       Date:  2002-05-28       Impact factor: 11.205

9.  A large community outbreak of salmonellosis caused by intentional contamination of restaurant salad bars.

Authors:  T J Török; R V Tauxe; R P Wise; J R Livengood; R Sokolow; S Mauvais; K A Birkness; M R Skeels; J M Horan; L R Foster
Journal:  JAMA       Date:  1997-08-06       Impact factor: 56.272

10.  Generating a synthetic genome by whole genome assembly: phiX174 bacteriophage from synthetic oligonucleotides.

Authors:  Hamilton O Smith; Clyde A Hutchison; Cynthia Pfannkoch; J Craig Venter
Journal:  Proc Natl Acad Sci U S A       Date:  2003-12-02       Impact factor: 11.205

View more
  13 in total

1.  Future infectious disease threats to Europe.

Authors:  Jonathan E Suk; Jan C Semenza
Journal:  Am J Public Health       Date:  2011-09-22       Impact factor: 9.308

Review 2.  Evolution of different dual-use concepts in international and national law and its implications on research ethics and governance.

Authors:  Johannes Rath; Monique Ischi; Dana Perkins
Journal:  Sci Eng Ethics       Date:  2014-02-05       Impact factor: 3.525

3.  Biological Dual-Use Research and Synthetic Biology of Yeast.

Authors:  Angela Cirigliano; Orlando Cenciarelli; Andrea Malizia; Carlo Bellecci; Pasquale Gaudio; Michele Lioj; Teresa Rinaldi
Journal:  Sci Eng Ethics       Date:  2016-06-20       Impact factor: 3.525

4.  Synthetic genomics and synthetic biology applications between hopes and concerns.

Authors:  Harald König; Daniel Frank; Reinhard Heil; Christopher Coenen
Journal:  Curr Genomics       Date:  2013-03       Impact factor: 2.236

5.  Requirements and design of the PROSPER protocol for implementation of information infrastructures supporting pandemic response: a Nominal Group study.

Authors:  Toomas Timpka; Henrik Eriksson; Elin A Gursky; Magnus Strömgren; Einar Holm; Joakim Ekberg; Olle Eriksson; Anders Grimvall; Lars Valter; James M Nyce
Journal:  PLoS One       Date:  2011-03-28       Impact factor: 3.240

6.  One study, two paths: the challenge of dual-use research.

Authors:  Wendee Holtcamp
Journal:  Environ Health Perspect       Date:  2012-06       Impact factor: 9.031

Review 7.  Biological Risks and Laboratory-Acquired Infections: A Reality That Cannot be Ignored in Health Biotechnology.

Authors:  Ana Cláudia Coelho; Juan García Díez
Journal:  Front Bioeng Biotechnol       Date:  2015-04-28

8.  The dual use of research ethics committees: why professional self-governance falls short in preserving biosecurity.

Authors:  Sabine Salloch
Journal:  BMC Med Ethics       Date:  2018-06-05       Impact factor: 2.652

9.  Restricted science.

Authors:  Sonia Ben Ouagrham-Gormley; Shannon R Fye
Journal:  Front Public Health       Date:  2014-09-24

10.  Dual-use research debates and public health: better integration would do no harm.

Authors:  Jonathan E Suk; Cornelius Bartels; Eeva Broberg; Marc J Struelens; Amanda J Ozin
Journal:  Front Public Health       Date:  2014-09-12
View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.